Julia Christine Botin

Article (news)

Agence France-Presse

<div> </div>KINSHASA, DR Congo — More than 16,000 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo (DRC) late Friday, an AFP journalist saw, as the country faces the deadliest Ebola outbreak in its history.The DRC&#x27;s 17th Ebola outbreak, which has killed thousands of people, was declared on May 15 but is thought to have been spreading for several weeks prior.<div><a class="fr-green fr-strong" href="https://www.abs-cbn.com/news/health-science/2026/7/10/ebola-outbreak-is-fastest-growing-ever-as-600-die-0939">READ: Ebola outbreak is &#x27;fastest growing ever&#x27; as 600 die</a></div>It has hit regions in the north and east where the presence of the state is weak, health infrastructure is largely lacking and myriad armed groups have roamed for decades.The World Health Organization (WHO) announced on Thursday that the DRC would receive a total of 70,000 doses of the Ervebo vaccine, produced in Germany.The vaccine, developed by the pharmaceutical company Merck, is approved against the Zaire strain of the virus, but not against the Bundibugyo strain currently circulating in the country.WHO experts still do not know whether Ervebo protects humans against the Bundibugyo strain, but early data, notably from animal trials, suggest it could offer some protection.The Ervebo vaccine &quot;has already been used several times, and in particular on a very large scale during the 2018–2020 outbreak&quot;, Samuel Roger Kamba, the DRC&#x27;s minister of health, told the press.He was speaking on the tarmac of Kinshasa airport, where a batch of 16,250 doses was delivered by plane on Friday.Of the 70,000 doses made available to the DRC, 20,000 are intended for a clinical trial, and 50,000 for &quot;frontline and health workers&quot; in the DRC, the WHO explained on Thursday.The Ebola outbreak in the DRC has already caused 2,516 deaths among 5,290 confirmed cases, according to the latest data published by the Congolese authorities.It &quot;is growing exponentially&quot;, warned Julien Harneis, the UN&#x27;s senior Ebola coordinator, on Friday.This month, WHO vaccine experts recommended a full-scale human trial of Ervebo, the only existing approved Ebola vaccine, to see if it offered cross-protection against the Bundibugyo strain.<div><a class="fr-green fr-strong" href="https://www.abs-cbn.com/news/health-science/2026/7/15/who-says-it-has-less-than-half-funding-needed-to-fight-ebola-1111">READ: WHO says it has less than half funding needed to fight Ebola</a></div>Two vaccines specifically targeting the Bundibugyo strain are in clinical trial phases: one is being developed by the US-based group Moderna, which uses mRNA technology, and the other by Britain&#x27;s University of Oxford.In addition, an &quot;rVSV Bundibugyo&quot; vaccine, described by the WHO as &quot;the most promising&quot;, is to be developed by Singapore-based Hilleman Laboratories.Ebola, which is transmitted through contact with bodily fluids and causes fever, has killed more than 15,000 people in Africa over the past 50 years.

More than 16,000 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo (DRC) late Friday, an AFP journalist saw, as the country faces the deadliest Ebola outbreak in its history.

More than 16,000 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo (DRC) late Friday, an AFP journalist saw, as the country faces the deadliest Ebola outbreak in its history.

More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DRC

News

Entertainment

Lifestyle

Sports

Metro.Style

More

BINI

Sudoku

Word of the Day

Lotto

Horoscope

World

More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DRC

Agence France-Presse

Published August 22, 2026 03:16 PM PHT

Read More:

Kinshasa

DR Congo

Ebola

vaccine

Ervebo vaccine

World Health Organization

WHO

ABS-CBN Newsletter

Your go-to source for the latest news, entertainment highlights, exclusive interviews, and updates on your favorite Kapamilya stars.

ABS-CBN Newsletter

Your go-to source for the latest news, entertainment highlights, exclusive interviews, and updates on your favorite Kapamilya stars.

Sign Up

I have read and agree to the Terms and Privacy Policy.

Haven't received our newsletter?

Check your inbox to verify and confirm your subscription. If you don’t see it, please check your spam or junk folder.

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.